Abstract Title:

Prophylactic treatment with MSC derived exosomes attenuates traumatic acute lung injury in rats.

Abstract Source:

Am J Physiol Lung Cell Mol Physiol. 2019 Mar 20. Epub 2019 Mar 20. PMID: 30892077

Abstract Author(s):

Qing-Chun Li, Yun Liang, Zhen-Bo Su

Article Affiliation:

Qing-Chun Li


Mesenchymal stem cell (MSC) is a potential strategy in the pretreatment of traumatic acute lung injury (ALI), a disease which causes inflammation and oxidative stress (OS). This study aimed to investigate whether MSCs-exosomal microRNA-124-3p (miR-124-3p) affects traumatic ALI. Initially, a traumatic ALI rat model was established using the weight-drop method. Then, exosomes were obtained from MSCs of Sprague-Dawley (SD) rats, which were injected into the traumatic ALI rats. We found that miR-124-3p was abundantly-expressed in MSCs-derived exosomes and could directly target purinergic receptor P2X ligand-gated ion channel 7 (P2X7), which was over-expressed in traumatic ALI rats. After that, a loss- and gain-of-function study was performed in MSCs and traumatic ALI rats to investigate the role of miR-124-3p and P2X7 in traumatic ALI. MSC-derived exosomal miR-124-3p or silenced P2X7 were observed to increase the survival rate of traumatic ALI rats and enhance the glutathione (GSH)/ superoxide dismutase (SOD) activity in their lung tissues. However, the wet/dry weight of lung tissues, activity of methylenedioxyamphetamine (MDA) and HO, and levels of inflammatory factors (TNF-a, IL-6, and IL-8) were reduced. Similarly, the numbers of total cells, macrophages, neutrophils and lymphocytes in bronchoalveolar lavage fluid (BALF) were also reduced when treated with exosomal miR-124-3p or silenced P2X7. In conclusion, the results provide evidence that miR-124-3p transferred by MSCs-derived exosomes inhibited P2X7 expression, thus improving OS injury and suppressing inflammatory response in traumatic ALI, highlighting a potential pretreatment for traumatic ALI.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.